Trouble for California Cloning?
Trouble for California Cloning? The United Nations will likely decide Friday, after many delays, whether to vote on an international […]
Trouble for California Cloning? The United Nations will likely decide Friday, after many delays, whether to vote on an international […]
The Murky History of Merck’s Vioxx Merck’s decision to withdraw its popular arthritis drug Vioxx from the market in late
The Murky History of Merck’s Vioxx Merck’s decision to withdraw its popular arthritis drug Vioxx from the market in late
Contingency Plans Help Current Merck Crisis : In the wake of Merck & Co.’s announcement to pull Vioxx off the
Reviewing Drug Safety “The Food & Drug Administration has announced a major review of its system for monitoring the safety
The Stem Cell Gold Rush: Scientists around the country who study embryonic stem cells may be mourning four more years
Financial Snapshot For September 2004 In need of a boost.
Biotech: The “safe” drug bet? “Defensive pharma stocks have struggled while biotechs have flourished. Can this continue?”
Biotech: The “safe” drug bet? “Defensive pharma stocks have struggled while biotechs have flourished. Can this continue?”
Biotech execs have a sense of humor about elusive profits When Ernst & Young’s annual report on the biotechnology industry
Biotech execs have a sense of humor about elusive profits Read Post »
Get new actionable insights and updates from BiotechBlog